Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 878, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.ejphar.2020.173105
Keywords
miR-199a-5p; NSCLC; Dox; ABCC1; HIF-1 alpha
Categories
Funding
- Natural Science Foundation of Shandong Province [ZR2019BH083]
- Youth Scientific Research Foundation of Affiliated Hospital of Qingdao University
Ask authors/readers for more resources
Non-small cell lung cancer (NSCLC) is one of the prevalent and deadly cancers worldwide. Chemotherapy resistance is one of the most challenging problems for NSCLC and other cancer treatment. Recent study suggested that miRNAs are involved in therapeutic functions of chemotherapy during cancer treatment. Our present study established doxorubicin (Dox) resistant NSCLC A549 and H460 cells (named A549Dox/R and H460 Dox/R). We found that miR-199a-5p was significantly down regulated in Dox resistant cells. Over expression of miR-199a-5p can increase the Dox sensitivity of resistant cells. Among various targets of miR-199a-5p, chemoresistance can increase the expression of ABCC1 and HIF-1 alpha. Gain and loss of function studies confirmed that both ABCC1 and HIF-1 alpha were involved in the chemoresistance of NSCLC cells. Collectively, our data showed that miR-199a-5p regulated expression of ABCC1 and HIF-1 alpha were involved in Dox resistance of NSCLC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available